Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ivor Douglas

Concepts (596)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
23
2024
528
3.950
 Why?
Sepsis
19
2024
507
2.890
 Why?
Respiratory Insufficiency
12
2023
286
2.420
 Why?
Fluid Therapy
11
2024
121
2.350
 Why?
Critical Care
18
2024
472
2.300
 Why?
Intensive Care Units
23
2024
614
2.230
 Why?
Critical Illness
19
2024
640
2.130
 Why?
Tracheostomy
5
2024
97
1.860
 Why?
Shock, Septic
11
2024
185
1.680
 Why?
Hospital Mortality
19
2024
773
1.610
 Why?
Shock
3
2024
83
1.480
 Why?
Hospitals
6
2023
581
1.350
 Why?
Pneumonia
7
2023
563
1.230
 Why?
Hypotension
4
2024
115
1.050
 Why?
Resuscitation Orders
3
2023
45
1.040
 Why?
Multiple Organ Failure
4
2024
116
1.000
 Why?
Humans
132
2025
114045
0.950
 Why?
Patient Readmission
6
2021
607
0.920
 Why?
Middle Aged
55
2025
26605
0.890
 Why?
Vasoconstrictor Agents
5
2023
113
0.890
 Why?
Ultrasonography, Doppler
1
2024
104
0.870
 Why?
Aged
42
2025
18969
0.860
 Why?
Pneumonia, Ventilator-Associated
2
2015
39
0.840
 Why?
Resuscitation
8
2024
221
0.800
 Why?
Safety-net Providers
3
2023
96
0.780
 Why?
Hemodynamics
3
2024
1015
0.770
 Why?
Severity of Illness Index
6
2021
2537
0.770
 Why?
Extracorporeal Membrane Oxygenation
2
2023
241
0.760
 Why?
Hospitals, High-Volume
2
2019
38
0.760
 Why?
Retrospective Studies
30
2024
12521
0.750
 Why?
Patient Acceptance of Health Care
5
2021
675
0.740
 Why?
Male
70
2025
55396
0.740
 Why?
Monitoring, Physiologic
4
2024
248
0.740
 Why?
Frailty
1
2023
113
0.730
 Why?
Patient Positioning
1
2021
41
0.720
 Why?
Diabetes Insipidus
1
2020
7
0.690
 Why?
Practice Guidelines as Topic
6
2021
1381
0.690
 Why?
Substance Withdrawal Syndrome
3
2021
159
0.650
 Why?
Hospitals, Low-Volume
1
2019
22
0.640
 Why?
Adult
43
2025
30375
0.630
 Why?
Female
61
2025
59324
0.620
 Why?
Dyspnea
2
2021
212
0.620
 Why?
Diabetes Mellitus
2
2020
898
0.580
 Why?
Alcoholism
5
2021
710
0.560
 Why?
Ventilator-Induced Lung Injury
3
2018
49
0.550
 Why?
California
5
2022
351
0.540
 Why?
Pulmonary Medicine
3
2015
69
0.540
 Why?
Neoplasms
3
2023
2086
0.540
 Why?
Microbiological Techniques
1
2016
29
0.520
 Why?
Sleep Medicine Specialty
1
2015
9
0.510
 Why?
Acute Kidney Injury
7
2023
637
0.500
 Why?
Acute Lung Injury
6
2023
268
0.500
 Why?
Randomized Controlled Trials as Topic
10
2023
1204
0.500
 Why?
Ethanol
2
2021
534
0.490
 Why?
Health Policy
4
2024
330
0.490
 Why?
Molecular Diagnostic Techniques
1
2016
92
0.490
 Why?
Hyperemia
3
2024
45
0.480
 Why?
Research Design
9
2023
919
0.470
 Why?
Cohort Studies
11
2023
4883
0.460
 Why?
Aged, 80 and over
12
2025
6306
0.450
 Why?
Pulmonary Disease, Chronic Obstructive
7
2017
907
0.440
 Why?
Renin-Angiotensin System
2
2025
72
0.440
 Why?
Bronchoalveolar Lavage Fluid
2
2016
580
0.430
 Why?
Inpatients
3
2023
378
0.430
 Why?
Prone Position
3
2021
27
0.430
 Why?
Receptor, EphA2
3
2018
19
0.430
 Why?
Cause of Death
3
2015
362
0.420
 Why?
Immune Tolerance
1
2015
321
0.420
 Why?
Nicotinic Agonists
1
2014
100
0.410
 Why?
Laryngoscopes
2
2023
38
0.400
 Why?
Dual Specificity Phosphatase 1
1
2012
28
0.400
 Why?
Cross Infection
5
2020
194
0.400
 Why?
Noninvasive Ventilation
3
2017
31
0.400
 Why?
Lung
12
2018
3521
0.400
 Why?
Marijuana Smoking
1
2015
224
0.400
 Why?
Apoptosis
6
2014
2349
0.390
 Why?
Pulmonary Fibrosis
4
2017
321
0.390
 Why?
Hospitalization
9
2025
1762
0.380
 Why?
Prospective Studies
12
2024
6195
0.380
 Why?
Immunity, Innate
1
2017
720
0.380
 Why?
Tobacco Use Disorder
1
2014
234
0.380
 Why?
Lipopolysaccharides
4
2017
813
0.380
 Why?
Nicotine
1
2014
265
0.380
 Why?
Organ Dysfunction Scores
2
2024
39
0.370
 Why?
Drug Delivery Systems
1
2014
295
0.370
 Why?
Tissue Plasminogen Activator
2
2024
204
0.370
 Why?
Child Development
1
2015
384
0.370
 Why?
Protein C
5
2012
43
0.360
 Why?
Delirium
2
2024
66
0.360
 Why?
Glycosaminoglycans
3
2016
79
0.360
 Why?
Emergency Service, Hospital
5
2024
1815
0.350
 Why?
Long-Term Care
2
2022
77
0.350
 Why?
United States
18
2024
12137
0.340
 Why?
Length of Stay
6
2024
957
0.340
 Why?
Smoking Cessation
1
2014
374
0.340
 Why?
Treatment Outcome
15
2024
9049
0.340
 Why?
Antipsychotic Agents
2
2024
183
0.330
 Why?
Comorbidity
4
2022
1447
0.330
 Why?
Public Health
1
2014
433
0.330
 Why?
Metabolic Syndrome
2
2023
320
0.330
 Why?
Vena Cava, Inferior
3
2024
56
0.320
 Why?
Cannabis
1
2015
383
0.320
 Why?
Ephrin-A1
3
2018
4
0.320
 Why?
Biomarkers
7
2023
3397
0.320
 Why?
Intubation, Intratracheal
4
2024
214
0.310
 Why?
Societies, Medical
7
2021
655
0.310
 Why?
Lipid A
2
2014
28
0.310
 Why?
Institutional Practice
1
2008
3
0.310
 Why?
Neutrophils
3
2024
1089
0.300
 Why?
Anti-Bacterial Agents
1
2017
1471
0.300
 Why?
Odds Ratio
6
2019
951
0.290
 Why?
Pandemics
4
2024
1310
0.290
 Why?
Personnel Staffing and Scheduling
1
2008
79
0.290
 Why?
Betacoronavirus
2
2020
247
0.290
 Why?
Integrins
1
2007
80
0.280
 Why?
Pulmonary Alveolar Proteinosis
1
2007
15
0.280
 Why?
Neovascularization, Pathologic
2
2007
280
0.280
 Why?
Renal Insufficiency, Chronic
2
2024
486
0.270
 Why?
MAP Kinase Signaling System
2
2014
271
0.270
 Why?
Lung Injury
3
2016
192
0.270
 Why?
Ultrasonography
3
2024
635
0.270
 Why?
Patient Admission
2
2023
175
0.270
 Why?
Hyponatremia
1
2006
37
0.260
 Why?
Double-Blind Method
9
2024
1656
0.260
 Why?
Lung Diseases, Obstructive
1
2006
40
0.260
 Why?
Leukocytes
1
2007
272
0.260
 Why?
Medicaid
3
2021
404
0.250
 Why?
Biomedical Research
3
2021
582
0.250
 Why?
Pneumonia, Viral
2
2020
334
0.250
 Why?
Coronavirus Infections
2
2020
326
0.250
 Why?
Laryngoscopy
2
2023
90
0.250
 Why?
Academic Medical Centers
3
2021
405
0.250
 Why?
Bronchi
1
2006
223
0.250
 Why?
Chemokines, CXC
1
2005
60
0.240
 Why?
Regeneration
1
2006
158
0.240
 Why?
Bronchiectasis
1
2006
106
0.240
 Why?
Oxazines
1
2024
25
0.240
 Why?
Bronchiolitis Obliterans
1
2005
66
0.240
 Why?
Adrenal Insufficiency
2
2013
26
0.240
 Why?
Infusions, Intravenous
5
2024
370
0.240
 Why?
Methylprednisolone
1
2005
80
0.230
 Why?
Hypoxia
3
2024
956
0.230
 Why?
Respiratory Mucosa
1
2006
251
0.230
 Why?
Venous Pressure
1
2024
8
0.230
 Why?
Phagocytosis
1
2006
349
0.230
 Why?
Cytokines
7
2017
1824
0.230
 Why?
Patient Protection and Affordable Care Act
2
2016
99
0.230
 Why?
Risk Factors
10
2021
8614
0.230
 Why?
Plasminogen
1
2024
29
0.230
 Why?
Morpholines
1
2024
102
0.230
 Why?
Vasopressins
3
2021
56
0.220
 Why?
Anti-Infective Agents
4
2012
219
0.220
 Why?
Leukocyte Elastase
1
2024
71
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2024
75
0.220
 Why?
beta Catenin
1
2005
218
0.220
 Why?
Renal Dialysis
4
2023
375
0.220
 Why?
Atrial Pressure
1
2023
4
0.220
 Why?
Receptor, Angiotensin, Type 1
1
2023
20
0.220
 Why?
Diterpenes
2
2014
31
0.210
 Why?
Craniocerebral Trauma
1
2005
133
0.210
 Why?
Lung Diseases
3
2016
690
0.210
 Why?
Area Under Curve
3
2020
273
0.210
 Why?
Haloperidol
2
2024
35
0.210
 Why?
Analgesics, Non-Narcotic
1
2024
117
0.210
 Why?
Hemodynamic Monitoring
1
2022
1
0.210
 Why?
Fibrinolysis
1
2024
126
0.210
 Why?
Fibrosis
1
2005
452
0.210
 Why?
Thiazoles
2
2024
110
0.210
 Why?
Treatment Failure
6
2021
330
0.200
 Why?
Evidence-Based Medicine
5
2016
662
0.190
 Why?
Clinical Decision-Making
1
2024
268
0.190
 Why?
Early Diagnosis
4
2017
217
0.190
 Why?
Transportation
1
2022
44
0.190
 Why?
Acetaminophen
1
2024
241
0.190
 Why?
Hydrocortisone
1
2003
267
0.190
 Why?
Logistic Models
7
2017
1829
0.190
 Why?
Pyridines
1
2024
419
0.190
 Why?
Stroke Volume
1
2024
513
0.180
 Why?
Vasodilator Agents
1
2023
302
0.180
 Why?
Heart Arrest
2
2021
293
0.180
 Why?
Receptors, Interleukin-6
1
2021
34
0.180
 Why?
Central Nervous System Depressants
1
2021
80
0.180
 Why?
Internship and Residency
2
2019
920
0.180
 Why?
Piperazines
2
2024
310
0.180
 Why?
Hospital Charges
1
2020
39
0.180
 Why?
Animals
20
2018
31565
0.180
 Why?
Community-Acquired Infections
3
2020
139
0.180
 Why?
Reproducibility of Results
5
2024
2764
0.180
 Why?
Rib Fractures
1
2020
25
0.180
 Why?
Health Priorities
1
2020
34
0.180
 Why?
Glucocorticoids
1
2005
526
0.180
 Why?
Hydroxychloroquine
1
2020
54
0.180
 Why?
Heart Failure
3
2023
1958
0.170
 Why?
Cell Proliferation
2
2014
2173
0.170
 Why?
Mice, Inbred C57BL
9
2018
4680
0.170
 Why?
Antigens, Differentiation
1
2000
79
0.170
 Why?
Patient Selection
1
2023
629
0.170
 Why?
Patient Handoff
1
2019
26
0.160
 Why?
Risk Adjustment
1
2020
76
0.160
 Why?
Age Factors
4
2019
2885
0.160
 Why?
Blood Glucose Self-Monitoring
1
2023
505
0.160
 Why?
Cell Adhesion Molecules
1
2000
167
0.160
 Why?
Hospital Costs
1
2019
104
0.160
 Why?
Combined Modality Therapy
2
2020
1117
0.160
 Why?
Dopamine Antagonists
1
2018
22
0.160
 Why?
Health Services Accessibility
4
2020
756
0.150
 Why?
ROC Curve
1
2020
441
0.150
 Why?
Thrombosis
1
2021
295
0.150
 Why?
Orthopedic Procedures
1
2020
206
0.150
 Why?
Antimicrobial Stewardship
1
2020
92
0.150
 Why?
Blood Glucose
2
2023
1827
0.150
 Why?
Eosinophils
1
2000
276
0.150
 Why?
Predictive Value of Tests
4
2016
1791
0.150
 Why?
Optometry
1
2017
2
0.140
 Why?
Mice
13
2017
14843
0.140
 Why?
Guideline Adherence
2
2014
489
0.140
 Why?
Platelet Count
2
2014
79
0.140
 Why?
Tidal Volume
2
2014
75
0.140
 Why?
Cell Adhesion
4
2012
426
0.140
 Why?
Pyrimidines
2
2024
374
0.140
 Why?
Cystic Fibrosis
1
2006
955
0.140
 Why?
Lymphocyte Count
1
2017
132
0.140
 Why?
Analysis of Variance
1
2020
1218
0.140
 Why?
Transients and Migrants
1
2017
22
0.140
 Why?
Attitude of Health Personnel
3
2019
970
0.140
 Why?
Delivery of Health Care
1
2023
828
0.130
 Why?
Antibodies, Monoclonal, Humanized
1
2021
660
0.130
 Why?
Tretinoin
1
2017
122
0.130
 Why?
Clinical Trials as Topic
1
2021
926
0.130
 Why?
Burnout, Professional
1
2021
323
0.130
 Why?
Nephrectomy
2
2008
149
0.130
 Why?
Ventricular Function, Right
1
2018
256
0.130
 Why?
Continuity of Patient Care
1
2018
252
0.130
 Why?
Health Insurance Exchanges
1
2016
2
0.130
 Why?
Sleep Wake Disorders
2
2017
232
0.130
 Why?
Risk Management
1
2017
89
0.130
 Why?
Breath Tests
1
2016
82
0.130
 Why?
Ventricular Dysfunction, Right
1
2018
221
0.130
 Why?
Staphylococcus aureus
2
2011
385
0.130
 Why?
Respiratory Tract Diseases
1
2017
139
0.120
 Why?
Prognosis
5
2021
3315
0.120
 Why?
Quality of Life
2
2024
2343
0.120
 Why?
Research
1
2018
389
0.120
 Why?
Patient Care Team
1
2019
517
0.120
 Why?
Survival Analysis
4
2014
1206
0.120
 Why?
Marriage
1
2016
105
0.120
 Why?
Risk Assessment
5
2015
2958
0.120
 Why?
Alcohol Withdrawal Seizures
1
2014
1
0.120
 Why?
Bronchoalveolar Lavage
1
2015
82
0.120
 Why?
Alcohol Withdrawal Delirium
1
2014
8
0.120
 Why?
Automation
1
2015
74
0.120
 Why?
Physicians
2
2021
765
0.120
 Why?
Multicenter Studies as Topic
3
2023
249
0.120
 Why?
Bacteriological Techniques
1
2015
63
0.120
 Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.120
 Why?
5-Lipoxygenase-Activating Proteins
1
2014
4
0.120
 Why?
Education, Medical
1
2017
214
0.120
 Why?
Catheterization, Central Venous
1
2015
83
0.120
 Why?
Fluorobenzenes
1
2014
11
0.120
 Why?
Leukotrienes
1
2014
33
0.120
 Why?
Phenanthrenes
1
2014
10
0.110
 Why?
Poverty
2
2016
440
0.110
 Why?
APACHE
2
2011
58
0.110
 Why?
CD4-Positive T-Lymphocytes
1
2000
959
0.110
 Why?
Down-Regulation
2
2017
594
0.110
 Why?
Potassium
1
2014
127
0.110
 Why?
Alanine Transaminase
1
2014
141
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2014
68
0.110
 Why?
Microscopy
1
2015
125
0.110
 Why?
Kaplan-Meier Estimate
5
2018
813
0.110
 Why?
Angiotensin II
2
2025
87
0.110
 Why?
Laryngeal Masks
1
2013
13
0.110
 Why?
Quinolines
1
2014
129
0.110
 Why?
Time Factors
7
2023
6077
0.100
 Why?
Health Knowledge, Attitudes, Practice
2
2024
1168
0.100
 Why?
Patient Discharge
1
2018
770
0.100
 Why?
Sensitivity and Specificity
2
2015
1690
0.100
 Why?
Cisplatin
1
2014
262
0.100
 Why?
Physician-Patient Relations
1
2017
459
0.100
 Why?
Patient-Centered Care
1
2017
470
0.100
 Why?
Glycocalyx
1
2012
18
0.100
 Why?
Acute Disease
3
2016
907
0.100
 Why?
Oxygen
3
2023
851
0.100
 Why?
Follow-Up Studies
5
2024
4392
0.100
 Why?
Supine Position
1
2012
32
0.100
 Why?
Indoles
1
2014
300
0.100
 Why?
Insurance, Health
1
2014
243
0.100
 Why?
Data Interpretation, Statistical
2
2011
318
0.100
 Why?
Biomarkers, Pharmacological
1
2012
26
0.100
 Why?
Health Status
1
2017
716
0.100
 Why?
Clinical Alarms
1
2011
9
0.100
 Why?
I-kappa B Proteins
1
2012
80
0.100
 Why?
Data Display
1
2011
19
0.100
 Why?
Endotoxemia
1
2012
86
0.090
 Why?
Adrenergic beta-2 Receptor Agonists
1
2011
32
0.090
 Why?
Albuterol
1
2011
102
0.090
 Why?
Genetic Markers
1
2012
320
0.090
 Why?
Sulfonamides
1
2014
444
0.090
 Why?
Decision Making
1
2017
760
0.090
 Why?
Fibrinolytic Agents
2
2024
231
0.090
 Why?
Interferons
1
2011
151
0.090
 Why?
Peroxidase
2
2008
161
0.090
 Why?
Alcohol-Related Disorders
1
2011
113
0.090
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
373
0.090
 Why?
Recombinant Proteins
5
2012
1228
0.090
 Why?
Survival Rate
3
2015
1638
0.090
 Why?
Disease Models, Animal
5
2018
3498
0.090
 Why?
Stenotrophomonas maltophilia
1
2009
2
0.090
 Why?
Clinical Protocols
2
2012
232
0.080
 Why?
Databases, Factual
2
2016
1125
0.080
 Why?
Thoracic Diseases
1
2009
13
0.080
 Why?
Cell Movement
3
2011
863
0.080
 Why?
Ligands
2
2023
556
0.080
 Why?
Adrenal Cortex Hormones
1
2013
493
0.080
 Why?
Gram-Negative Bacterial Infections
1
2009
36
0.080
 Why?
Symptom Assessment
2
2020
119
0.080
 Why?
Blotting, Western
1
2012
1143
0.080
 Why?
Wounds and Injuries
1
2016
674
0.080
 Why?
Polymerase Chain Reaction
1
2012
990
0.080
 Why?
Cues
1
2011
301
0.080
 Why?
Up-Regulation
1
2012
802
0.080
 Why?
Confidence Intervals
1
2010
302
0.080
 Why?
Age Distribution
1
2010
341
0.080
 Why?
Sex Distribution
1
2010
336
0.080
 Why?
Pancreatitis
1
2009
105
0.080
 Why?
Healthcare Disparities
1
2014
479
0.080
 Why?
Pneumonia, Bacterial
1
2009
103
0.080
 Why?
Pulmonary Alveoli
2
2012
372
0.080
 Why?
Incidence
1
2014
2314
0.080
 Why?
Models, Statistical
1
2012
595
0.080
 Why?
Work Schedule Tolerance
1
2008
35
0.080
 Why?
Clinical Trials, Phase III as Topic
2
2023
82
0.070
 Why?
Child, Preschool
2
2015
9114
0.070
 Why?
United Kingdom
1
2008
226
0.070
 Why?
Disease Progression
4
2017
2371
0.070
 Why?
Clinical Competence
1
2014
882
0.070
 Why?
Interleukin-6
2
2008
673
0.070
 Why?
Signal Transduction
4
2018
4501
0.070
 Why?
Rats, Sprague-Dawley
1
2012
2182
0.070
 Why?
Workload
1
2008
131
0.070
 Why?
Pulmonary Emphysema
2
2007
267
0.070
 Why?
Carcinoma, Non-Small-Cell Lung
1
1995
959
0.070
 Why?
Flavonoids
1
2007
66
0.070
 Why?
Mandatory Programs
1
2007
14
0.070
 Why?
Adolescent
5
2025
17800
0.070
 Why?
Demeclocycline
1
2006
3
0.070
 Why?
Mice, Inbred C3H
1
2007
242
0.070
 Why?
Young Adult
5
2025
10444
0.070
 Why?
Methicillin Resistance
1
2006
19
0.070
 Why?
Lithium Compounds
1
2006
9
0.070
 Why?
Sex Factors
3
2018
1706
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
145
0.070
 Why?
Rats
2
2012
4913
0.070
 Why?
Mitogen-Activated Protein Kinase 1
1
2007
164
0.070
 Why?
Diuretics
1
2006
64
0.070
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
97
0.070
 Why?
Hospitals, Urban
2
2018
128
0.070
 Why?
Protein Kinase Inhibitors
2
2024
784
0.070
 Why?
Mesoderm
1
2007
138
0.070
 Why?
Intercellular Adhesion Molecule-1
2
2012
147
0.060
 Why?
Hospital Information Systems
1
2006
13
0.060
 Why?
History, 20th Century
2
2017
265
0.060
 Why?
Hypertension, Pulmonary
2
2007
1736
0.060
 Why?
Mice, Inbred BALB C
2
2005
1144
0.060
 Why?
Occupational Health
1
2008
165
0.060
 Why?
Radiography, Thoracic
1
2007
150
0.060
 Why?
Heparin
1
2007
225
0.060
 Why?
Bronchoscopy
1
2007
196
0.060
 Why?
Butylated Hydroxytoluene
1
2005
31
0.060
 Why?
Asparagine
1
2005
29
0.060
 Why?
Vocabulary
1
2006
41
0.060
 Why?
Gene Expression Profiling
1
2012
1518
0.060
 Why?
Gene Expression Regulation
2
2012
2322
0.060
 Why?
Emphysema
1
2006
106
0.060
 Why?
Cyclin D1
1
2005
61
0.060
 Why?
Cell Line, Transformed
1
2005
133
0.060
 Why?
Venous Thrombosis
1
2007
141
0.060
 Why?
Medical Order Entry Systems
1
2006
41
0.060
 Why?
Blood Vessels
1
2007
179
0.060
 Why?
Caspase Inhibitors
1
2005
77
0.060
 Why?
Macrophages
2
2014
1259
0.060
 Why?
Angiotensin I
1
2025
5
0.060
 Why?
Ischemia
1
2008
361
0.060
 Why?
Necrosis
1
2005
209
0.060
 Why?
Androstanols
1
2024
5
0.060
 Why?
Neuromuscular Nondepolarizing Agents
1
2024
8
0.060
 Why?
Colorado
4
2017
4090
0.060
 Why?
HMGB1 Protein
1
2005
47
0.060
 Why?
Hope
1
2024
13
0.060
 Why?
Diabetic Ketoacidosis
1
2007
161
0.060
 Why?
Pyridazines
1
2024
46
0.060
 Why?
Caspases
1
2005
243
0.060
 Why?
Cadherins
1
2005
175
0.060
 Why?
Practice Patterns, Physicians'
3
2024
1175
0.060
 Why?
T-Lymphocyte Subsets
1
2006
383
0.060
 Why?
Renal Replacement Therapy
1
2024
66
0.060
 Why?
Mental Health
2
2022
559
0.060
 Why?
Medicago
1
2023
1
0.060
 Why?
Uncertainty
1
2024
91
0.060
 Why?
Steroids
2
2021
143
0.060
 Why?
Enzyme Inhibitors
1
2007
743
0.060
 Why?
Atrial Function, Right
1
2023
12
0.050
 Why?
Autoimmune Diseases
1
2006
381
0.050
 Why?
Inflammatory Bowel Diseases
1
2007
284
0.050
 Why?
Angiotensins
1
2023
10
0.050
 Why?
Antineoplastic Agents
1
2014
1875
0.050
 Why?
Multivariate Analysis
2
2017
1422
0.050
 Why?
Collagen
1
2005
414
0.050
 Why?
Decision Support Techniques
2
2020
336
0.050
 Why?
Biopsy
1
2007
1024
0.050
 Why?
Heparitin Sulfate
2
2014
39
0.050
 Why?
Drug Administration Schedule
2
2018
714
0.050
 Why?
Homeostasis
1
2006
570
0.050
 Why?
Anticoagulants
1
2007
547
0.050
 Why?
Child
2
2015
18401
0.050
 Why?
Diagnosis, Differential
1
2007
1331
0.050
 Why?
Lung Neoplasms
1
1995
2159
0.050
 Why?
Video Recording
1
2023
141
0.050
 Why?
Staphylococcal Infections
1
2006
340
0.050
 Why?
Hemoglobins
1
2024
308
0.050
 Why?
Infant
1
2015
7943
0.050
 Why?
Creatinine
2
2015
424
0.050
 Why?
Endothelial Cells
1
2007
677
0.050
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
249
0.050
 Why?
Lung Diseases, Interstitial
1
2007
495
0.050
 Why?
Partial Thromboplastin Time
1
2021
50
0.050
 Why?
Oligopeptides
1
2023
234
0.050
 Why?
Perioperative Care
1
2022
126
0.050
 Why?
Electrocardiography
1
2024
561
0.050
 Why?
Peptide Fragments
1
2025
665
0.050
 Why?
Antibodies
2
2018
365
0.050
 Why?
Hemorrhage
1
2005
600
0.040
 Why?
Chronic Disease
1
2006
1577
0.040
 Why?
Leukotriene C4
1
2000
12
0.040
 Why?
CD18 Antigens
1
2000
25
0.040
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
52
0.040
 Why?
Glasgow Coma Scale
1
2020
151
0.040
 Why?
CD11 Antigens
1
2000
27
0.040
 Why?
Drug Resistance, Microbial
1
2020
66
0.040
 Why?
Epithelial Cells
1
2005
946
0.040
 Why?
Costs and Cost Analysis
1
2020
196
0.040
 Why?
Surveys and Questionnaires
3
2021
4595
0.040
 Why?
Oxidative Stress
1
2005
1068
0.040
 Why?
Needs Assessment
1
2021
315
0.040
 Why?
Flow Cytometry
2
2017
1075
0.040
 Why?
Smoking
1
2006
1382
0.040
 Why?
Algorithms
1
2006
1469
0.040
 Why?
Aftercare
1
2001
186
0.040
 Why?
Hospitals, University
1
2019
169
0.040
 Why?
NF-kappa B
2
2018
636
0.040
 Why?
Mice, Knockout
3
2012
2562
0.040
 Why?
T-Lymphocytes
1
2006
1735
0.040
 Why?
Infection Control
1
2020
132
0.040
 Why?
Adjuvants, Immunologic
1
2000
206
0.040
 Why?
Injury Severity Score
1
2020
472
0.040
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
2
0.040
 Why?
Linear Models
1
2020
768
0.040
 Why?
Trauma Centers
1
2020
347
0.040
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
36
0.040
 Why?
Family
1
2022
589
0.040
 Why?
Mortality
1
2019
283
0.040
 Why?
Victoria
1
2017
15
0.040
 Why?
Antigens, CD
1
2000
440
0.040
 Why?
History, 17th Century
1
2017
15
0.040
 Why?
History, 16th Century
1
2017
14
0.040
 Why?
History, 15th Century
1
2017
11
0.040
 Why?
Recovery of Function
1
2021
573
0.040
 Why?
Cross-Sectional Studies
2
2021
4402
0.030
 Why?
History, Ancient
1
2017
47
0.030
 Why?
United Arab Emirates
1
2017
5
0.030
 Why?
History, Medieval
1
2017
40
0.030
 Why?
Drug Therapy, Combination
2
2012
949
0.030
 Why?
Critical Care Outcomes
1
2016
12
0.030
 Why?
History, 21st Century
1
2017
160
0.030
 Why?
Refugees
1
2017
54
0.030
 Why?
Trauma Severity Indices
1
2016
108
0.030
 Why?
Probability
1
2017
286
0.030
 Why?
Lymphocyte Activation
1
2000
1036
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2018
397
0.030
 Why?
Anxiety
1
2022
843
0.030
 Why?
Pilot Projects
1
2019
1360
0.030
 Why?
Socioeconomic Factors
1
2018
1080
0.030
 Why?
Uteroglobin
1
2014
16
0.030
 Why?
Cost-Benefit Analysis
1
2017
544
0.030
 Why?
Chemokine CXCL2
1
2014
41
0.030
 Why?
Arachidonate 5-Lipoxygenase
1
2014
43
0.030
 Why?
Nitrates
1
2014
71
0.030
 Why?
Rosuvastatin Calcium
1
2014
17
0.030
 Why?
MAP Kinase Kinase 4
1
2014
23
0.030
 Why?
Nitrites
1
2014
74
0.030
 Why?
Risk
1
2017
810
0.030
 Why?
Creatine Kinase
1
2014
75
0.030
 Why?
Quality Indicators, Health Care
1
2017
285
0.030
 Why?
Epoxy Compounds
1
2014
31
0.030
 Why?
Quality Improvement
1
2021
944
0.030
 Why?
Liver Failure
1
2014
73
0.030
 Why?
Chondroitin Sulfates
1
2014
33
0.030
 Why?
Leukocyte Count
1
2014
292
0.030
 Why?
Toll-Like Receptor 2
1
2014
110
0.030
 Why?
Kidney Function Tests
1
2014
140
0.030
 Why?
Depression
1
2022
1133
0.030
 Why?
Manikins
1
2013
23
0.030
 Why?
Chromatography, Liquid
1
2015
345
0.030
 Why?
Bronchial Spasm
1
2013
4
0.030
 Why?
Cryptogenic Organizing Pneumonia
1
2013
17
0.030
 Why?
Mass Spectrometry
1
2016
622
0.030
 Why?
Contraindications
1
2013
84
0.030
 Why?
Anesthesiology
1
2013
35
0.030
 Why?
Tandem Mass Spectrometry
1
2015
410
0.030
 Why?
Protein C Deficiency
1
2012
2
0.030
 Why?
Cells, Cultured
1
2000
3861
0.030
 Why?
Connective Tissue Diseases
1
2013
71
0.030
 Why?
Glucuronidase
1
2012
42
0.030
 Why?
Knowledge Bases
1
2012
17
0.030
 Why?
Renal Insufficiency
1
2014
137
0.030
 Why?
Intestinal Perforation
1
2012
39
0.020
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
73
0.020
 Why?
Quality of Health Care
1
2017
572
0.020
 Why?
Triage
1
2014
197
0.020
 Why?
Disease Management
1
2016
556
0.020
 Why?
Water-Electrolyte Balance
1
2011
26
0.020
 Why?
Adoptive Transfer
1
2012
194
0.020
 Why?
Endothelium
1
2012
109
0.020
 Why?
Quality Assurance, Health Care
1
2014
308
0.020
 Why?
Toll-Like Receptor 4
1
2014
285
0.020
 Why?
Cross-Over Studies
1
2013
439
0.020
 Why?
Epistasis, Genetic
1
2012
66
0.020
 Why?
General Surgery
1
2013
125
0.020
 Why?
Cell Survival
1
2014
1014
0.020
 Why?
Internal Medicine
1
2013
211
0.020
 Why?
Longitudinal Studies
1
2017
2384
0.020
 Why?
Microbial Viability
1
2011
79
0.020
 Why?
Arthroplasty, Replacement, Knee
1
2014
246
0.020
 Why?
Superoxides
1
2011
190
0.020
 Why?
Enzyme Activation
1
2012
771
0.020
 Why?
Interleukin-8
1
2011
229
0.020
 Why?
Cell Separation
1
2011
290
0.020
 Why?
Viruses
1
2011
94
0.020
 Why?
Single-Payer System
1
2009
2
0.020
 Why?
Survivors
1
2013
412
0.020
 Why?
Species Specificity
1
2011
541
0.020
 Why?
Disease-Free Survival
1
2011
618
0.020
 Why?
Administration, Inhalation
1
2011
637
0.020
 Why?
Cell Death
1
2011
322
0.020
 Why?
Case-Control Studies
1
2016
3003
0.020
 Why?
Nitric Oxide
1
2014
817
0.020
 Why?
Information Dissemination
1
2011
185
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2011
787
0.020
 Why?
Self Report
1
2013
695
0.020
 Why?
Advisory Committees
1
2010
207
0.020
 Why?
Cell Line
1
2014
2629
0.020
 Why?
Drug Resistance, Bacterial
1
2009
156
0.020
 Why?
Precision Medicine
1
2012
335
0.020
 Why?
Microbial Sensitivity Tests
1
2009
300
0.020
 Why?
Total Quality Management
1
2008
61
0.020
 Why?
Ventilator Weaning
1
2008
33
0.020
 Why?
Placebos
1
2008
197
0.020
 Why?
Neutrophil Infiltration
1
2008
94
0.020
 Why?
Capillary Permeability
1
2008
137
0.020
 Why?
United States Food and Drug Administration
1
2008
172
0.020
 Why?
Health Plan Implementation
1
2008
132
0.020
 Why?
Interdisciplinary Communication
1
2008
183
0.020
 Why?
Drug Industry
1
2008
103
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2012
1128
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
1836
0.020
 Why?
Chemokines
1
2008
215
0.020
 Why?
Acid-Base Equilibrium
1
2007
29
0.020
 Why?
Umbilical Veins
1
2006
57
0.020
 Why?
Cost Control
1
2006
39
0.020
 Why?
CD8 Antigens
1
2006
69
0.020
 Why?
Ketones
1
2007
44
0.020
 Why?
Microcirculation
1
2007
133
0.020
 Why?
Medical Audit
1
2007
75
0.020
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
103
0.020
 Why?
Bacillus subtilis
1
2006
58
0.020
 Why?
CD4 Antigens
1
2006
123
0.020
 Why?
Information Management
1
2006
15
0.020
 Why?
Cell Count
1
2006
303
0.020
 Why?
Genome-Wide Association Study
1
2012
1176
0.020
 Why?
Fluorescent Antibody Technique
1
2006
396
0.020
 Why?
User-Computer Interface
1
2006
141
0.020
 Why?
Interleukin-10
1
2006
293
0.010
 Why?
Polymorphism, Single Nucleotide
1
2012
1880
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
239
0.010
 Why?
Asthma
1
2017
2021
0.010
 Why?
Inflammation Mediators
1
2006
475
0.010
 Why?
Hypoglycemia
1
2007
386
0.010
 Why?
Endothelium, Vascular
1
2007
830
0.010
 Why?
Cardiotonic Agents
1
2001
121
0.010
 Why?
Hypothermia, Induced
1
2001
66
0.010
 Why?
Mass Screening
1
2006
979
0.010
 Why?
RNA, Messenger
1
2006
2550
0.010
 Why?
Hypoglycemic Agents
1
2007
1011
0.010
 Why?
Dopamine
1
2001
235
0.010
 Why?
Anti-Inflammatory Agents
1
2001
445
0.010
 Why?
Insulin
1
2007
2080
0.010
 Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (596) concept(s)
_
Co-Authors Expand Description
See all (60) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)